Int'l : +1(646) 832-2886 | query@kbvresearch.com
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV Research, The Global AI in Evidence Access and Networks Market size is expected to reach USD 2,961.50 Million by 2033, rising at a market growth of 17.0% CAGR during the forecast period.
The Global AI in Evidence Access and Networks Market is rapidly transforming healthcare and life sciences intelligence by enabling organizations to aggregate, analyze, and distribute large volumes of clinical, operational, genomic, and real-world healthcare data through interconnected digital ecosystems. The increasing demand for real-world evidence (RWE), healthcare interoperability, precision medicine, and evidence-based decision-making is accelerating adoption across pharmaceutical companies, healthcare providers, payers, and research institutions.
The Data Platforms and Networks segment is leading the Global AI in Evidence Access and Networks Market by Component in 2025; thereby, achieving a market value of USD 1,517.0 Million by 2033. The growing need for integrated healthcare data ecosystems capable of aggregating, managing, and exchanging clinical, operational, and real-world evidence data continues to drive segment growth. Healthcare organizations, pharmaceutical companies, and research institutions are increasingly deploying advanced healthcare data networks to improve interoperability, accelerate evidence generation, and support more informed healthcare decision-making. The rising focus on connected healthcare ecosystems and collaborative evidence-sharing frameworks is further strengthening demand for data platform solutions.
The Natural Language Processing (NLP) segment is generating the maximum revenue share in the Global AI in Evidence Access and Networks Market by Technology in 2025. NLP technologies are increasingly being utilized to analyze large volumes of unstructured healthcare data, including physician notes, clinical documentation, electronic health records, and medical literature. By converting complex textual information into actionable insights, NLP solutions enable faster evidence generation, improved clinical intelligence, and enhanced research productivity. Growing adoption of AI-powered healthcare analytics and the increasing volume of healthcare data continue to drive demand for advanced NLP capabilities.
The Pharmaceutical and Biotech Companies segment is generating the maximum revenue share in the Global AI in Evidence Access and Networks Market by End User in 2025. Pharmaceutical and biotechnology organizations are increasingly investing in AI-enabled evidence generation platforms to support drug development, clinical trial optimization, regulatory intelligence, and precision medicine initiatives. The ability to leverage real-world evidence and advanced analytics for faster and more informed decision-making is helping organizations improve research outcomes, accelerate innovation, and strengthen competitive positioning within the healthcare ecosystem.
The Electronic Health Records (EHR) segment is leading the Global AI in Evidence Access and Networks Market by Data Source in 2025; thereby, achieving a market value of USD 904.9 Million by 2033. The widespread adoption of digital healthcare systems and the growing availability of structured clinical information have positioned EHRs as a foundational data source for evidence generation. Healthcare organizations are increasingly utilizing EHR data to support clinical research, patient stratification, population health management, treatment optimization, and regulatory-grade evidence development. The continued expansion of digital health infrastructure is expected to further strengthen segment growth.
Full Report: https://www.kbvresearch.com/ai-in-evidence-access-and-networks-market/
The North America region dominated the Global AI in Evidence Access and Networks Market by Region in 2025 and would continue to be a dominant market till 2033; thereby, achieving a market value of USD 1,305.1 Million by 2033. The Europe region is expected to witness a CAGR of 16.8% during (2026-2033). North America continues to lead the market due to advanced healthcare analytics infrastructure, widespread adoption of artificial intelligence technologies, strong healthcare data availability, and the presence of leading healthcare technology providers. Meanwhile, Europe is benefiting from increasing healthcare digitalization, interoperability initiatives, and growing investments in evidence-based healthcare systems, while Asia Pacific continues to emerge as a significant growth market driven by expanding healthcare infrastructure, AI adoption, and healthcare research investments.
By Component
By Technology
By End User
By Data Source
By Geography
Related Reports: